Antibody-drug conjugates that bind to human oncology targets are disclosed. The antibody- drug conjugates comprise a Bcl-xL inhibitor drug moiety. The disclosure further relates to methods and compositions for use in the treatment of cancers by administering the antibody- drug conjugates provided herein. Linker-drug conjugates comprising Bcl-xL inhibitor drug moiety and methods of making same are also disclosed.
本文揭示了结合人类肿瘤靶点的
抗体药物偶联物。这些
抗体药物偶联物包括Bcl-xL
抑制剂药物部分。本文还涉及使用本文提供的
抗体药物偶联物治疗癌症的方法和组合物。本文还揭示了包含Bcl-xL
抑制剂药物部分的连接剂-药物偶联物及其制备方法。